TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314606. A total of 26 filers reported holding TITAN PHARMACEUTICALS INC DE in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,892 | -26.6% | 82,051 | 0.0% | 0.00% | – |
| Q2 2023 | $53,021 | -22.1% | 82,051 | 0.0% | 0.00% | – |
| Q1 2023 | $68,102 | +6.0% | 82,051 | 0.0% | 0.00% | – |
| Q4 2022 | $64,254 | -27.0% | 82,051 | +0.2% | 0.00% | – |
| Q3 2022 | $88,000 | +109.5% | 81,924 | +9.4% | 0.00% | – |
| Q2 2022 | $42,000 | -78.7% | 74,895 | -63.7% | 0.00% | – |
| Q1 2022 | $197,000 | -6.2% | 206,428 | 0.0% | 0.00% | – |
| Q4 2021 | $210,000 | -45.6% | 206,428 | -0.1% | 0.00% | – |
| Q3 2021 | $386,000 | -27.3% | 206,695 | +1.2% | 0.00% | – |
| Q2 2021 | $531,000 | +144.7% | 204,324 | +180.7% | 0.00% | – |
| Q1 2021 | $217,000 | +16.7% | 72,791 | +28.4% | 0.00% | – |
| Q4 2020 | $186,000 | – | 56,691 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 863,512 | $826,000 | 0.02% |
| Level Financial Advisors | 987 | $1,000 | 0.00% |
| Westside Investment Management, Inc. | 4 | $0 | 0.00% |
| Fortitude Advisory Group L.L.C. | 8 | $0 | 0.00% |
| American Portfolios Advisors | 23 | $22 | 0.00% |
| Renaissance Technologies | 36,510 | $35,000 | 0.00% |
| BARCLAYS PLC | 50,050 | $48,000 | 0.00% |
| VANGUARD GROUP INC | 206,428 | $197,000 | 0.00% |
| UBS Group AG | 7,123 | $7,000 | 0.00% |
| IFP Advisors, Inc | 844 | $3,000 | 0.00% |